Milner Therapeutics Institute

The Milner Therapeutics Institute (MTI) is a research Institute at the University of Cambridge, located on the Cambridge Biomedical Research Campus, within the Jeffrey Cheah Biomedical Centre built in 2019. The overarching vision of the MTI is to harness academic excellence to accelerate the drug development process and convert pioneering science into novel therapies. The Institute provides a unique working environment, with start-ups, academics and pharma companies working side by side at the bench. Working across multiple therapeutic areas, it has one of the largest concentrations of expertise in functional genomics at the University, with access to a breadth of expertise in technical development and screening across academia and industry.

The computational research group led by Dr Namshik Han is developing cutting-edge computational methods and applying them to identify new, or better, drug targets from the analysis of biomedical datasets across therapeutic areas. The areas of research include the development and application of artificial intelligence, machine learning, statistical and mathematical approaches to pharmacogenomics and drug discovery.

https://www.jobs.cam.ac.uk/job/33809/